Review Article

Clinical Efficacy and Meta-Analysis of Stem Cell Therapies for Patients with Brain Ischemia

Table 1

Study characteristic report.

AuthorYear of publishNumbers
(SCs/Con)
AgeType of stroke
Acute/chronic
Gender
Male/female
Type of interventionsCells dose
×106
Route of injectionFollow-up
(month)
Outcome effect indicators
Stem cellControl

Bang et al. [9]20055/2563.0 ± 7.5Acute18/12MSCRoutine100Intravenous12Barthel
Sun et al. [10]200820/2257.8 ± 8.9X32/10MSCRoutineXIntravenous3NIHSS
Niu et al. [11]201016/2056 ± 7Chronic22/14NSCRoutineXSubarachnoid6FIM
Bhasin et al. [12]20116/642Chronic8/4MSCRoutine50–60Intravenous6FMA, Barthel
Deng et al. [13]201215/15XAcuteXMSCRoutine10–50Intravenous1NIHSS
He [14]201220/1856.4 ± 7.9X23/15MSCRoutine100Intravenous3NIHSS
Bhasin et al. [15]201212/1246.5ChronicXMNCRoutine50–60Intravenous6FMA, Barthel
Xiao [16]201378/8256.9 ± 9.2X103/57NSCRoutine8000SubarachnoidXFIM
Bhasin et al. [17]201314/2045.1 ± 12.1Chronic32/8MNCRoutine50–60Intravenous6FMA, Barthel
6/2045.1 ± 12.1Chronic32/8MSCRoutine50–60Intravenous6FMA, Barthel
Liu et al. [18]201429/2955.3 ± 3.6Acute38/20MSCRoutine100Subarachnoid3NIHSS, Barthel, FMA
Xie et al. [19]201430/3051.4 ± 7.2Acute37/23MSCRoutineXSubarachnoid6NIHSS, Barthel
Chen et al. [20]201415/1550.1 ± 7.7Chronic20/10PBSCRoutine3–8Stereotactic12NIHSS
Prasad et al. [21]201460/6050.7 ± 11.6Acute77/43MSCRoutine280.75Intravenous12NIHSS, Barthel
Zhang et al. [22]201514/2857.2 ± 7.3X34/26NSCRoutine40Intravenous6FIM
18/2856.9 ± 7.5X34/26NSCRoutine40Subarachnoid6FIM
Shen [23]201516/1652 ± 10.4AcuteXUC-MSCRoutine1000Intra-carotid3FIM
Cai et al. [24]201521/2161.4 ± 6.7Chronic27/15MSCRoutine150–600Intravenous6FIM, FMA, Barthel

MSC: mesenchymal stem cell; NSC: neural stem cell; MNC: bone marrow mononuclear stem cells; PBSC: peripheral blood stem cell; UC-MSC: umbilical cord blood mesenchymal stem cell; X: unknown.